The focus of the present study was to further elucidate role of OLR1as an oncogene based on the premise that as a sensor of dyslipidemia and a moleculeinvolved in NF-kB activation, OLR1 may be a link betweendyslipidemia and cancer. This evidence concerns the gene OLR1 and metabolic syndrome.